Inspections Prompt EU Advice On Validating Computerized Clinical Trial Systems
Executive Summary
Deficiencies relating to the qualification and validation of computerized systems used for managing clinical trial data remains an ongoing concern for the European Medicines Agency, which has now issued advice on the matter.
You may also be interested in...
EMA Finalizes Key Guideline On Use Of Digital Tech To Capture Electronic Trial Data
The European Medicines Agency has published a keenly awaited guidance document on how to use computerized systems in clinical trials while ensuring data integrity and patient rights.
EMA Finalizes Key Guideline On Use Of Digital Tech To Capture Electronic Trial Data
The European Medicines Agency has published a keenly awaited guidance document on how to use computerized systems in clinical trials while ensuring data integrity and patient rights.
EMA Clarifies Sponsor's Role In Validating Electronic Systems Used In Clinical Trials
The European Medicines Agency has issued guidance in response to a growing number of queries from sponsors on how they should qualify/validate the electronic systems they use in a clinical trial setting when the systems have already been qualified by a vendor. The issue has already resulted in deviations being issued during good clinical practice inspections.